Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antisense compounds targeting genes associated with usher syndrome

Antisense compounds targeting genes associated with usher syndrome

US Patent 9353371 · Granted May 31, 2016

Estimated economic value: $22,999,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antisense oligonucleotides directed to huntingtin2025
Compounds and methods for modulating GFAP2025
Conjugated antisense compounds and their use2025
Methods for reducing Ataxin-2 expression2025
Selective reduction of allelic variants2024
Antisense compounds targeting genes associated with cystic fibrosis2024
Compositions and methods for detection of SMN protein in a subject and treatment2024
Compounds and methods for reducing ATXN2 expression2024
Oligomeric compounds for reducing DMPK expression2023
Compositions for modulating Ataxin 2 expression2023
Compounds and methods for modulating GFAP2023
Methods for treating Alzheimer's disease2023